{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:53:51Z","timestamp":1790193231465,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1496-y","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T12:04:41Z","timestamp":1443441881000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Service users\u2019 and carers\u2019 views on research towards stratified medicine in psychiatry: a qualitative study"],"prefix":"10.1186","volume":"8","author":[{"given":"Diana","family":"Rose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantina","family":"Papoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"issue":"2","key":"1496_CR1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/0269881112443746","volume":"27","author":"DR Owen","year":"2013","unstructured":"Owen DR, Rupprecht R, Nutt DJ. Stratified medicine in psychiatry: a worrying example or new opportunity in the treatment of anxiety? J Psychopharmacol. 2013;27(2):119\u201322.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"1496_CR2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.20.3.719","volume":"20","author":"CL Vogel","year":"2002","unstructured":"Vogel CL, Cobleigh MA, Tripathy D, Gutheil JC, Harris LN, Fehrenbacher L, Slamon DJ, Murphy M, Novotny WF, Burchmore M, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002;20(3):719\u201326.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1496_CR3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2013.245","volume":"10","author":"PM Matthews","year":"2014","unstructured":"Matthews PM, Edison P, Geraghty OC, Johnson MR. The emerging agenda of stratified medicine in neurology. Nat Rev Neurol. 2014;10(1):15\u201326.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1496_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.euroneuro.2013.09.010","volume":"24","author":"G Schumann","year":"2014","unstructured":"Schumann G, Binder EB, Holte A, de Kloet ER, Oedegaard KJ, Robbins TW, Walker-Tilley TR, Bitter I, Brown VJ, Buitelaar J, et al. Stratified medicine for mental disorders. Eur Neuropsychopharmacol. 2014;24(1):5\u201350.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"1496_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15622975.2012.696143","volume":"13","author":"A Hasan","year":"2012","unstructured":"Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, Moller HJ, Treatment WTF. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012;13(5):318\u201378.","journal-title":"World J Biol Psychiatry"},{"key":"1496_CR6","doi-asserted-by":"crossref","unstructured":"Wunderlink L., Nieboer R.M., Wiersma D, Sytema S, Nienhuis FJ. Recovery in remitted first episode psychosis at 7\u00a0years follow-up of an early dose reduction\/discontinuation or maintenance treatment strategy: long term follow up of a 2-year randomized clinical trial. JAMA Psychiatry. 2013;70(9):913\u201320.","DOI":"10.1001\/jamapsychiatry.2013.19"},{"issue":"1\u20133","key":"1496_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.02.1071","volume":"119","author":"SM Francey","year":"2010","unstructured":"Francey SM, Nelson B, Thompson A, Parker AG, Kerr M, Macneil C, Fraser R, Hughes F, Crisp K, Harrigan S, et al. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res. 2010;119(1\u20133):1\u201310.","journal-title":"Schizophr Res"},{"issue":"12","key":"1496_CR8","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/mp.2012.105","volume":"17","author":"S Kapur","year":"2012","unstructured":"Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatr. 2012;17(12):1174\u20139.","journal-title":"Mol Psychiatr"},{"issue":"6","key":"1496_CR9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/09638237.2010.520367","volume":"19","author":"S Patterson","year":"2010","unstructured":"Patterson S, Kramo K, Soteriou T, Crawford MJ. The great divide: a qualitative investigation of factors influencing researcher access to potential randomised controlled trial participants in mental health settings. J Ment Health. 2010;19(6):532\u201341.","journal-title":"J Ment Health"},{"issue":"3\u20134","key":"1496_CR10","first-page":"138","volume":"43","author":"E Finn","year":"2008","unstructured":"Finn E, McNulty M, Carr A, O\u2019Callaghan E. Service users\u2019 views of the benefits of and barriers to mental health research participation. Int J Psychol. 2008;43(3\u20134):138.","journal-title":"Int J Psychol"},{"issue":"1","key":"1496_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cct.2008.07.007","volume":"30","author":"L Howard","year":"2009","unstructured":"Howard L, de Salis I, Tomlin Z, Thornicroft G, Donovan J. Why is recruitment to trials difficult? An investigation into recruitment difficulties in an RCT of supported employment in patients with severe mental illness. Contemp Clin Trials. 2009;30(1):40\u20136.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"1496_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/09540261.2010.546777","volume":"23","author":"A Woodall","year":"2011","unstructured":"Woodall A, Howard L, Morgan C. Barriers to participation in mental health research: findings from the genetics and psychosis (GAP) study. Int Rev Psychiatry. 2011;23(1):31\u201340.","journal-title":"Int Rev Psychiatry"},{"key":"1496_CR13","volume-title":"Stratified medicine: a public dialogue. Headline findings to the Technology Strategy Board","author":"L Farrow","year":"2014","unstructured":"Farrow L, Beddoes D. Stratified medicine: a public dialogue. Headline findings to the Technology Strategy Board. London: OPM Group; 2014."},{"key":"1496_CR14","doi-asserted-by":"crossref","unstructured":"Kerath SM, Klein G, Kern M, Shapira I, Witthuhn J, Norohna N, Kline M, Baksh F, Gregersen P, Taioli E: Beliefs and attitudes towards participating in genetic research\u2014a population based cross-sectional study. BMC Public Health. 2013;13:114.","DOI":"10.1186\/1471-2458-13-114"},{"issue":"6","key":"1496_CR15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1467-9566.2008.01116.x","volume":"30","author":"M Barr","year":"2008","unstructured":"Barr M, Rose D. The great ambivalence: factors likely to affect service user and public acceptability of the pharmacogenomics of antidepressant medication. Sociol Health Ill. 2008;30(6):944\u201358.","journal-title":"Sociol Health Ill"},{"issue":"7252","key":"1496_CR16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/460202a","volume":"460","author":"I Singh","year":"2009","unstructured":"Singh I, Rose N. Biomarkers in psychiatry. Nature. 2009;460(7252):202\u20137.","journal-title":"Nature"},{"issue":"5","key":"1496_CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0447.2006.00824.x","volume":"114","author":"J Read","year":"2006","unstructured":"Read J, Haslam N, Sayce L, Davies E. Prejudice and schizophrenia: a review of the \u2018mental illness is an illness like any other\u2019 approach. Acta Psychiatr Scand. 2006;114(5):303\u201318.","journal-title":"Acta Psychiatr Scand"},{"issue":"11","key":"1496_CR18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","volume":"169","author":"A Demjaha","year":"2012","unstructured":"Demjaha A, Murray RM, McGuire PK, Kapur S, Howes OD. Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am J Psychiatry. 2012;169(11):1203\u201310.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1496_CR19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1192\/bjp.bp.112.110999","volume":"202","author":"E Papanastasiou","year":"2013","unstructured":"Papanastasiou E, Stone JM, Shergill S. When the drugs don\u2019t work: the potential of glutamatergic antipsychotics in schizophrenia. Br J Psychiatry. 2013;202(2):91\u20133.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"1496_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09638230801931944","volume":"17","author":"F Callard","year":"2008","unstructured":"Callard F, Wykes T. Mental health and perceptions of biomarker research\u2014possible effects on participation. J Ment Health. 2008;17(1):1\u20137.","journal-title":"J Ment Health"},{"issue":"3","key":"1496_CR21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/0162243906298354","volume":"32","author":"JF Caron-Flinterman","year":"2007","unstructured":"Caron-Flinterman JF, Broerse JEW, Bunders JFG. Patient partnership in decision-making on biomedical research\u2014Changing the network. Sci Technol Hum Val. 2007;32(3):339\u201368.","journal-title":"Sci Technol Hum Val"},{"issue":"3","key":"1496_CR22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1369-7625.2010.00634.x","volume":"14","author":"ILMA Baart","year":"2011","unstructured":"Baart ILMA, Abma TA. Patient participation in fundamental psychiatric genomics research: a Dutch case study. Health Expect. 2011;14(3):240\u20139.","journal-title":"Health Expect"},{"issue":"5","key":"1496_CR23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.bp.112.119818","volume":"203","author":"L Ennis","year":"2013","unstructured":"Ennis L, Wykes T. Impact of patient involvement in mental health research: longitudinal study. Br J Psychiatry. 2013;203(5):381\u20136.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"1496_CR24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/1740774505cn065oa","volume":"2","author":"AL Langston","year":"2005","unstructured":"Langston AL, McCallum M, Campbell MK, Robertson C, Ralston SH. An integrated approach to consumer representation and involvement in a multicentre randomized controlled trial. Clin Trials. 2005;2(1):80\u20137.","journal-title":"Clin Trials"},{"issue":"4","key":"1496_CR25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1369-7625.2011.00681.x","volume":"15","author":"F Callard","year":"2012","unstructured":"Callard F, Rose D, Wykes T. Close to the bench as well as at the bedside: involving service users in all phases of translational research. Health Expect. 2012;15(4):389\u2013400.","journal-title":"Health Expect"},{"key":"1496_CR26","volume-title":"Transforming qualitative information: thematic analysis and code development","author":"RE Boyatzis","year":"1998","unstructured":"Boyatzis RE. Transforming qualitative information: thematic analysis and code development. Thousand Oaks: Sage Publications; 1998."},{"issue":"2","key":"1496_CR27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"1496_CR28","doi-asserted-by":"crossref","unstructured":"Rose D, Russo J, Wykes T. Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process. BMC Med Ethics. 2013;14:34.","DOI":"10.1186\/1472-6939-14-34"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1496-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T16:22:15Z","timestamp":1498234935000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1756-0500\/8\/489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1496-y","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]},"article-number":"489"}}